MAI Capital Management Has $857,000 Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

MAI Capital Management reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 29.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,771 shares of the medical research company’s stock after selling 2,421 shares during the quarter. MAI Capital Management’s holdings in Agilent Technologies were worth $857,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of A. Western Pacific Wealth Management LP lifted its position in shares of Agilent Technologies by 18.9% during the 1st quarter. Western Pacific Wealth Management LP now owns 440 shares of the medical research company’s stock worth $64,000 after buying an additional 70 shares during the last quarter. Menard Financial Group LLC raised its stake in Agilent Technologies by 1.6% during the second quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock worth $628,000 after acquiring an additional 77 shares in the last quarter. McAdam LLC lifted its holdings in shares of Agilent Technologies by 3.1% in the third quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock worth $376,000 after acquiring an additional 77 shares during the last quarter. Global Retirement Partners LLC boosted its stake in shares of Agilent Technologies by 3.2% in the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock valued at $382,000 after purchasing an additional 79 shares in the last quarter. Finally, Rovin Capital UT ADV grew its holdings in shares of Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after purchasing an additional 81 shares during the last quarter.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $131.94 on Friday. The business has a 50-day moving average price of $137.97 and a two-hundred day moving average price of $137.72. Agilent Technologies, Inc. has a 1-year low of $123.48 and a 1-year high of $155.35. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The company has a market cap of $37.91 billion, a P/E ratio of 27.37, a PEG ratio of 5.53 and a beta of 1.07.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm’s revenue for the quarter was down 5.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.43 earnings per share. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.75%. The ex-dividend date is Tuesday, December 31st. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s payout ratio is presently 19.50%.

Insider Buying and Selling

In related news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This represents a 19.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Wall Street Analysts Forecast Growth

A has been the subject of several research reports. Citigroup increased their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Stifel Nicolaus restated a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Wells Fargo & Company started coverage on Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price for the company. TD Cowen boosted their price target on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Finally, Bank of America lifted their target price on shares of Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.